Skip to main content

Main navigation

  • Expertise
  • Publications & Insights
  • People
  • Careers

Secondary navigation

  • Value added services
  • CSR
  • About us

SearchSearch results for: “”

385 results

Stibbe represents the bankruptcy trustees of Amsterdam hospital MC Slotervaart in dispute with the City of Amsterdam

Stibbe represented the bankruptcy trustees of  the Amsterdam hospital MC Slotervaart in proceedings against the City of Amsterdam, centred on the City’s demand that the bankruptcy trustees investigate whether there were any irregularities prior to the ban

Stibbe advises Excess Materials Exchange (EME)

Stibbe advises Excesss Materials Exchange, a digital facilitated marketplace B2B platform for excess materials trade, on legal matters including setting up the articles of association, structure, employment law, data protection, and defining "waste".

Stibbe advises DW Healthcare Partners

Stibbe advised DW Healthcare Partners, a private equity investment firm, on the acquisition of CEFALY Technology, a company active in the healthcare sector.

Wat betekent de PAS-uitspraak van de Afdeling voor de toelaatbaarheid van stikstofrelevante activiteiten?

Op 29 mei 2019 heeft de Afdeling bestuursrechtspraak van de Raad van State ("Afdeling") in haar langverwachte uitspraak geoordeeld dat het PAS in strijd met de Habitatrichtlijn is vastgesteld.

Afdeling stelt grens aan opleggen duurzaamheidseisen via zorgplicht of milieuvergunning aan bedrijven

De Afdeling bestuursrechtspraak van de Raad van State ("Afdeling") heeft op 17 april 2019 een belangrijke uitspraak gewezen voor de milieupraktijk.

Stibbe advises Hardt

Stibbe advises Hardt on legal aspects in relation to the development of the Hyperloop technology.

Daan Doorenbos

Partner Amsterdam

Stibbe advises Aedifica

Stibbe advised Aedifica on the acquisition of a healthcare residence for the elderly in Franeker (Friesland).

Stibbe advises Agendia

Stibbe advised Agendia on securing a $35 million investment from funds managed by Athyrium Capital Management.

Stibbe advises Canon Medical Systems

Stibbe advised Canon Medical Systems on the acquisition of Dutch medical equipment manufacturer Fysicon.

Stibbe advises Aedifica

Stibbe advises Aedifica on the acquisition of a care residence to be constructed in Bosch en Duin (municipality of Zeist).

Stibbe advises Aedifica

Stibbe advises Aedifica on the acquisition of three healthcare residences for the elderly at Leiden, Oss and Amersfoort. The three residences are operated by ECR/Blueprint Group. 

Stibbe advises on the equity offering of ProQR

Stibbe advised the joint bookrunners Citigroup, Evercore ISI and RBC Capital Markets and the co-managers on the $104.1 million equity offering of ProQR Therapeutics N.V. ("ProQR"). 

Stibbe advises Lundbeck

Stibbe advised Lundbeck on the acquisition of Prexton Therapeutics BV for an amount of up to EUR 905 million.

Het Besluit stikstofreductie en natuurverbetering is ter consultatie gegaan

De minister van LNV had er verschillende oppositiepartijen voor nodig, maar het is haar gelukt: begin december 2020 werd bekend dat er voldoende steun is voor de Wet stikstofreductie en natuurverbetering (ook wel: de stikstofwet, of de “Wsn”).

De vierde handelsperiode van het Europees emissiehandelssysteem (ETS-IV): een overzicht van belangrijke wijzigingen per 1 januari 2021

Op 1 januari 2021 begint de vierde handelsperiode van het Europees Emissiehandelssysteem voor CO2 emissierechten (hierna ook: ETS-IV).  ETS-IV bevat een aantal wijzigingen ten opzichte van de derde handelsperiode (hierna: ETS-III).

ESG: The Transition to ESG Benchmarks and new ESG disclosure requirements

Marking a substantial step towards achieving the goals of the EU Action Plan on Financing Sustainable Growth (the “EU Action Plan on Sustainable Growth”), the benchmark regulations will enter into force on 23 December 2020.

Webinar: The contraversial Bayer judgment and its potential impact on patent litigation in Europe

Philippe Campolini, IP partner at Stibbe in Brussels, acts as panelist in a webinar organised by EPLAW (the European Patent Lawyers Association) on the contraversial Bayer judgment and its potential impact on patent litigation in Europe.

Pagination

  • Previous page
  • Page 9
  • Current page 10
  • Page 11
  • Page 12
  • Next page
Reset filters
Date
Content type
  • Article (196)
  • Event (21)
  • Inside Stibbe (8)
  • Interview (1)
  • Matter (58)
  • Podcast (10)
  • People (91)
Expertise
  • (-) ESG & Sustainability (307)
  • (-) Healthcare and Life Sciences (85)
  • Audit Firms and Accountancy (76)
  • Banking and Finance (437)
  • Capital Markets (251)
  • Compliance, Sanctions and Risk (162)
  • Corporate and M&A (884)
  • Corporate Investigations (32)
  • Criminal Law and Enforcement (148)
  • Employment, Benefits and Pensions (419)
  • Energy, Industry and Climate (320)
  • Environment and Planning (913)
  • EU and Competition Law (486)
  • Financial Regulation (176)
  • Infrastructure and Mobility (205)
  • Insurance (36)
  • Intellectual Property (120)
  • Investment Funds (147)
  • Litigation and Arbitration (435)
  • Mass Litigation (92)
  • Privacy and Data Protection (206)
  • Private Equity (200)
  • Procurement Law (128)
  • Public Law (1219)
  • Real Estate (487)
  • Restructuring and Insolvency (116)
  • Sports (27)
  • Tax (454)
  • Tech (197)
  • Technology, Media and Telecommunications (339)
  • Unfair Competition and Consumer Protection (200)
Jurisdiction
  • BE Law (39)
  • EU Law (83)
  • LU Law (15)
  • NL Law (245)
Language
  • Dutch (145)
  • English (234)
  • French (6)

Footer main navigation

  • Expertise
  • Publications & Insights
  • People
  • Careers
© 2025 Stibbe

Footer navigation

  • Contact
  • Disclaimer
  • General Conditions
  • Register of legal practice areas
  • Privacy and Cookie Policy
  • Important Information